Skip to content

H2020HORIZONFP7

Fondazione Toscana Life Sciences

Country
ITItaly
Defence projects
0
Projects, all programmes
14
As coordinator
4
EU contribution (CORDIS)
EUR 13,206,278
Active
2009 to 2024

Projects

14 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
ArTCellBottom-up manufacturing of artificial anti-tumor T cellsHORIZON2024ParticipantEUR 546,500
PROACTIVEPROposing Action to ConTrol and Impede betacoronaVirus EmergenciesHORIZON2023CoordinatorEUR 2,498,750
EP PerMedEuropean Partnership for Personalised MedicineHORIZON2023ParticipantEUR 682,200
MammoScreenInnovative and safe microwave-based imaging technology to make breast cancer screening more accurate, inclusive and female-friendlyHORIZON2022CoordinatorEUR 3,178,672
BornToGetThereImplementation of early detection and early intervention service delivery in infants at risk for cerebral palsy to promote infants’ psychomotor development and maternal healthH20202020ParticipantEUR 429,700
SINO-EU-PerMedWidening Sino‐EU policy and research cooperation in Personalised MedicineH20202020ParticipantEUR 429,882
VACCIBIOMECancer Vaccines and Gut Microbiome: a rational approach to optimize cancer immunotherapyH20202019ParticipantEUR 1,487,500
REGIONS4PERMEDINTERREGIONAL COORDINATION FOR A FAST AND DEEP UPTAKE OF PERSONALISED HEALTHH20202018CoordinatorEUR 702,090
vAMResVaccines as a remedy for antimicrobial resistant bacterial infectionsH20202018CoordinatorEUR 2,432,500
OMVCRCEngineered bacterial Outer Membrane Vesicles (OMVs) for colorectal cancer immunotherapyH20202018ParticipantEUR 56,250
TRANSCAN-2ERA-NET: Aligning national/regional translational cancer research programmes and activitiesH20202015Third partyNot stated
OMVACOuter Membrane Vesicles (OMVs) from “Vaccinobacter”: A Synthetic Biology approach for effective vaccines against infectious diseases and cancerFP72014ParticipantEUR 497,150
NERRINeuro-Enhancement: Responsible Research and InnovationFP72013ParticipantEUR 147,414
EPISODEExploiting the Potential of Structural Biology through NMR and Associated Technologies - Opportunities for Economic Development of Pharma/Biotech in Tuscany, Berlin-Brandenburg and BeyondFP72009ParticipantEUR 117,670

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.